Trial record 1 of 1 for:    CA220-007
Previous Study | Return to List | Next Study

Safety Study of IL-21/Ipilimumab Combination in the Treatment of Melanoma

This study has been completed.
Information provided by (Responsible Party):
Bristol-Myers Squibb Identifier:
First received: December 7, 2011
Last updated: August 28, 2014
Last verified: August 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2014
  Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)